Essential Concepts in the Use of Somatostatin Analogues in Patients with Neuroendocrine Tumors
03/24/2015 - 03/24/2016
Pamela L. Kunz, MD
CME Released: 03/24/2015; Valid for credit through 03/24/2016
This activity is intended for oncologists, nurses, pharmacists, and other healthcare providers who manage patients with advanced neuroendocrine tumors (NETs).
The goal of this activity is to discuss the management of patients with NETs with a focus on somatostatin analogues.
Upon completion of this activity, participants will be able to:
- Evaluate available clinical data on the treatment of patients with advanced NETs
- Outline common strategies and treatment paradigms in the management of NETs